Human Genome Epidemiology Literature Finder
|
Records 1 - 6 (of 6 Records) |
| Query Trace: Neoplasms and PTPN2[original query] |
|---|
| Loss of protein tyrosine phosphatase, non-receptor type 2 is associated with activation of AKT and tamoxifen resistance in breast cancer. Breast cancer research and treatment 2015 Aug 153 (1): 31-40. Karlsson Elin, Veenstra Cynthia, Emin Shad, Dutta Chhanda, Pérez-Tenorio Gizeh, Nordenskjöld Bo, Fornander Tommy, Stål Ol |
| Genetic variants of PTPN2 are associated with lung cancer risk: a re-analysis of eight GWASs in the TRICL-ILCCO consortium. Scientific reports 2017 Apr 7 (1): 825. Feng Yun, Wang Yanru, Liu Hongliang, Liu Zhensheng, Mills Coleman, Han Younghun, Hung Rayjean J, Brhane Yonathan, McLaughlin John, Brennan Paul, Bickeboeller Heike, Rosenberger Albert, Houlston Richard S, Caporaso Neil E, Teresa Landi Maria, Brueske Irene, Risch Angela, Ye Yuanqing, Wu Xifeng, Christiani David C, Amos Christopher I, Wei Qing |
| PTPN2 deficiency along with activation of nuclear Akt predict endocrine resistance in breast cancer. Journal of cancer research and clinical oncology 2019 Mar 145 (3): 599-607. Karlsson Elin, Veenstra Cynthia, Gårsjö Jon, Nordenskjöld Bo, Fornander Tommy, Stål Ol |
| ERBB2 and PTPN2 gene copy numbers as prognostic factors in HER2-positive metastatic breast cancer treated with trastuzumab. Oncology letters 2019 3 17 (3): 3371-3381. Ellegård Sander, Veenstra Cynthia, Pérez-Tenorio Gizeh, Fagerström Victor, Gårsjö Jon, Gert Krista, Sundquist Marie, Malmström Annika, Wingren Sten, Elander Nils O, Hallbeck Anna-Lotta, Stål Ol |
| Whole-genome sequencing of a sporadic primary immunodeficiency cohort. Nature 2020 6 583 (7814): 90-95. Thaventhiran James E D, Lango Allen Hana, Burren Oliver S, Rae William, Greene Daniel, Staples Emily, Zhang Zinan, Farmery James H R, Simeoni Ilenia, Rivers Elizabeth, Maimaris Jesmeen, Penkett Christopher J, Stephens Jonathan, Deevi Sri V V, Sanchis-Juan Alba, Gleadall Nicholas S, Thomas Moira J, Sargur Ravishankar B, Gordins Pavels, Baxendale Helen E, Brown Matthew, Tuijnenburg Paul, Worth Austen, Hanson Steven, Linger Rachel J, Buckland Matthew S, Rayner-Matthews Paula J, Gilmour Kimberly C, Samarghitean Crina, Seneviratne Suranjith L, Sansom David M, Lynch Andy G, Megy Karyn, Ellinghaus Eva, Ellinghaus David, Jorgensen Silje F, Karlsen Tom H, Stirrups Kathleen E, Cutler Antony J, Kumararatne Dinakantha S, Chandra Anita, Edgar J David M, Herwadkar Archana, Cooper Nichola, Grigoriadou Sofia, Huissoon Aarnoud P, Goddard Sarah, Jolles Stephen, Schuetz Catharina, Boschann Felix, , Lyons Paul A, Hurles Matthew E, Savic Sinisa, Burns Siobhan O, Kuijpers Taco W, Turro Ernest, Ouwehand Willem H, Thrasher Adrian J, Smith Kenneth G |
| Functional informed genome-wide interaction analysis of body mass index, diabetes and colorectal cancer risk. Cancer medicine 2020 3 9 (10): 3563-3573. Xia Zhiyu, Su Yu-Ru, Petersen Paneen, Qi Lihong, Kim Andre E, Figueiredo Jane C, Lin Yi, Nan Hongmei, Sakoda Lori C, Albanes Demetrius, Berndt Sonja I, Bézieau Stéphane, Bien Stephanie, Buchanan Daniel D, Casey Graham, Chan Andrew T, Conti David V, Drew David A, Gallinger Steven J, Gauderman W James, Giles Graham G, Gruber Stephen B, Gunter Marc J, Hoffmeister Michael, Jenkins Mark A, Joshi Amit D, Le Marchand Loic, Lewinger Juan P, Li Li, Lindor Noralane M, Moreno Victor, Murphy Neil, Nassir Rami, Newcomb Polly A, Ogino Shuji, Rennert Gad, Song Mingyang, Wang Xiaoliang, Wolk Alicja, Woods Michael O, Brenner Hermann, White Emily, Slattery Martha L, Giovannucci Edward L, Chang-Claude Jenny, Pharoah Paul D P, Hsu Li, Campbell Peter T, Peters Ulri |
- Page last reviewed:Feb 1, 2024
- Content source: